These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 5338163)

  • 1. [Detection of antinuclear antibodies by immuno-fluorescence. Comparative study with other technics].
    Rodríguez A; Vallone EF; Somma RE; Canto RM; Bauzá CA; Tosi HC
    An Fac Med Univ Repub Montev Urug; 1965; 50(5):407-13. PubMed ID: 5338163
    [No Abstract]   [Full Text] [Related]  

  • 2. [The autoimmune diseases in pediatrics].
    Salazar De Sousa C; Marques Pinto L
    Minerva Pediatr; 1966 Oct; 18(29):1616-52. PubMed ID: 5993445
    [No Abstract]   [Full Text] [Related]  

  • 3. [The mechanism of autoimmune cutaneous diseases].
    Jablonska S; Chorzelski T
    Ann Dermatol Syphiligr (Paris); 1971; 98(4):377-92. PubMed ID: 4945246
    [No Abstract]   [Full Text] [Related]  

  • 4. [Incidence of antinuclear factors, studied by immunofluorescence, of 563 blood samples of subjects with collagen diseases and other disease states].
    Del Giacco GS; Mignone V; Davoli C; Novi C
    Reumatismo; 1966; 18(3):146-50. PubMed ID: 5338008
    [No Abstract]   [Full Text] [Related]  

  • 5. Antimuscle factor and antinuclear factor in patients with myasthenia gravis. 1. Heavy chain determinants.
    McFarlin DE; Johnson JS SEYMOUR WF
    J Immunol; 1968 Jul; 101(1):104-10. PubMed ID: 4173933
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antibodies to adult T-cell leukemia-associated antigen (ATLA) in hematological and collagen diseases--comparison of the gelatin particle agglutination (PA) and indirect immunofluorescence (IF) methods].
    Nakayama S; Ishikawa T; Yabe H; Nagai K; Yata H; Imai J
    Rinsho Ketsueki; 1986 Aug; 27(8):1332-8. PubMed ID: 3025472
    [No Abstract]   [Full Text] [Related]  

  • 7. [Study of antinuclear autoantibodies by immunofluorescence technic in collagen diseases].
    Fontaine J; Panisset LC
    Union Med Can; 1969 Aug; 98(8):1274-83. PubMed ID: 4919613
    [No Abstract]   [Full Text] [Related]  

  • 8. [The evidence of antibodies against motor endplates of the skeletal muscle in myasthenia gravis with the double immune-fluorescence technique (author's transl)].
    Storch W; Trautmann B
    Acta Histochem; 1981; 69(1):18-22. PubMed ID: 6795885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to tissues.
    Steffen C
    Prog Clin Pathol; 1970; 3():226-64. PubMed ID: 4950006
    [No Abstract]   [Full Text] [Related]  

  • 10. [Descriptive and comparative study of technical methods used for the detection of antinuclear antibodies].
    Abuaf N
    Ann Biol Clin (Paris); 1982; 40(2):65-74. PubMed ID: 6812470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New aspects of antinuclear antibodies].
    Kurki P; Gripenberg M
    Duodecim; 1981; 97(15):1135-8. PubMed ID: 6799268
    [No Abstract]   [Full Text] [Related]  

  • 12. [Nonspecific immuno-serum factors in chronic hepatitis].
    Fodor O; Parau N
    Rev Int Hepatol; 1967 May; 17(6):589-604. PubMed ID: 5300721
    [No Abstract]   [Full Text] [Related]  

  • 13. [Current problems in immunohematology].
    Ricci C; Blefari D
    Minerva Med; 1971 May; 62(38):1934-40. PubMed ID: 4103283
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antinuclear antibodies. Diagnostic significance and methods of detection].
    Bootello A; Kreisler M
    Rev Clin Esp; 1975 Oct; 139(1):47-52. PubMed ID: 1105704
    [No Abstract]   [Full Text] [Related]  

  • 15. Striational antibodies in myasthenia gravis: reactivity and possible clinical significance.
    Romi F; Skeie GO; Gilhus NE; Aarli JA
    Arch Neurol; 2005 Mar; 62(3):442-6. PubMed ID: 15767509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antinuclear antibodies: study by liver imprint technique.
    Ulrich M; Convit J
    Acta Cient Venez; 1973; 24(1):34-7. PubMed ID: 4590089
    [No Abstract]   [Full Text] [Related]  

  • 17. Myasthenia gravis: therapeutical-immunological correlation.
    de Assis JL; Saraiva S
    Rev Hosp Clin Fac Med Sao Paulo; 1971; 26(6):213-6. PubMed ID: 4950682
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antinuclear antibody: significance of fluorescence patterns].
    Habermann F; de Franco MF
    Rev Hosp Clin Fac Med Sao Paulo; 1981 Jun; 36(3):123-7. PubMed ID: 7034129
    [No Abstract]   [Full Text] [Related]  

  • 19. [The problem of slightly speckled cell nucleus reaction in the immunofluorescent technical analysis of antinuclear factors].
    Bäumer A; Brinkmann A
    Z Rheumaforsch; 1970; 29(9):264-9. PubMed ID: 4919618
    [No Abstract]   [Full Text] [Related]  

  • 20. [Research on anti-leukocyte fluorescent antibodies in collagen diseases and other dermatological diseases].
    Moroni P; Silvestri U
    Arch Ital Dermatol Venereol Sessuol; 1966; 34(4):243-50. PubMed ID: 4869278
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.